Cargando…

An integrated RF-receive/B(0)-shim array coil boosts performance of whole-brain MR spectroscopic imaging at 7 T

Metabolic imaging of the human brain by in-vivo magnetic resonance spectroscopic imaging (MRSI) can non-invasively probe neurochemistry in healthy and disease conditions. MRSI at ultra-high field (≥ 7 T) provides increased sensitivity for fast high-resolution metabolic imaging, but comes with techni...

Descripción completa

Detalles Bibliográficos
Autores principales: Esmaeili, Morteza, Stockmann, Jason, Strasser, Bernhard, Arango, Nicolas, Thapa, Bijaya, Wang, Zhe, van der Kouwe, Andre, Dietrich, Jorg, Cahill, Daniel P., Batchelor, Tracy T., White, Jacob, Adalsteinsson, Elfar, Wald, Lawrence, Andronesi, Ovidiu C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490394/
https://www.ncbi.nlm.nih.gov/pubmed/32929121
http://dx.doi.org/10.1038/s41598-020-71623-5
Descripción
Sumario:Metabolic imaging of the human brain by in-vivo magnetic resonance spectroscopic imaging (MRSI) can non-invasively probe neurochemistry in healthy and disease conditions. MRSI at ultra-high field (≥ 7 T) provides increased sensitivity for fast high-resolution metabolic imaging, but comes with technical challenges due to non-uniform B(0) field. Here, we show that an integrated RF-receive/B(0)-shim (AC/DC) array coil can be used to mitigate 7 T B(0) inhomogeneity, which improves spectral quality and metabolite quantification over a whole-brain slab. Our results from simulations, phantoms, healthy and brain tumor human subjects indicate improvements of global B(0) homogeneity by 55%, narrower spectral linewidth by 29%, higher signal-to-noise ratio by 31%, more precise metabolite quantification by 22%, and an increase by 21% of the brain volume that can be reliably analyzed. AC/DC shimming provide the highest correlation (R(2) = 0.98, P = 0.001) with ground-truth values for metabolite concentration. Clinical translation of AC/DC and MRSI is demonstrated in a patient with mutant-IDH1 glioma where it enables imaging of D-2-hydroxyglutarate oncometabolite with a 2.8-fold increase in contrast-to-noise ratio at higher resolution and more brain coverage compared to previous 7 T studies. Hence, AC/DC technology may help ultra-high field MRSI become more feasible to take advantage of higher signal/contrast-to-noise in clinical applications.